Cargando…
Relative Safety and Efficacy of Two Doses of Tandospirone Citrate for Generalized Anxiety Disorder: A Multicenter Randomized Controlled Trial
PURPOSE: To determine the relative safety and efficacy of different doses of tandospirone in treating generalized anxiety disorder (GAD). PATIENTS AND METHODS: This parallel randomized controlled trial enrolled patients with GAD from eight centers in China. The patients were randomly assigned to 60...
Autores principales: | Li, Qingwei, Zhang, Haiyin, Lin, Guozhen, Shi, Shenxun, Zhang, Yingli, Ji, Jianlin, Yang, Lipeng, Yao, Jun, Wu, Wenyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9374096/ https://www.ncbi.nlm.nih.gov/pubmed/35968511 http://dx.doi.org/10.2147/NDT.S366048 |
Ejemplares similares
-
Pharmacokinetics and absorption mechanism of tandospirone citrate
por: Li, Rong, et al.
Publicado: (2023) -
Clinical Analysis on the Effects of Tandospirone Citrate Assisted by Drawing Therapy on Medication Compliance and Sleep Quality in Patients with Anxiety Disorders
por: Hou, Jichong, et al.
Publicado: (2022) -
EEG power spectral analysis reveals tandospirone improves anxiety symptoms in patients with Alzheimer’s disease: a prospective cohort study
por: Liao, Zhengluan, et al.
Publicado: (2021) -
Apocynin-Tandospirone Derivatives Suppress Methamphetamine-Induced Hyperlocomotion in Rats with Neonatal Exposure to Dizocilpine
por: Uehara, Takashi, et al.
Publicado: (2022) -
Efficacy and safety of metformin plus low-dose temozolomide in patients with recurrent or refractory glioblastoma: a randomized, prospective, multicenter, double-blind, controlled, phase 2 trial (KNOG-1501 study)
por: Yoon, Wan-Soo, et al.
Publicado: (2023)